Doctors say clot treatment advice key to U.S. resuming J&J COVID vaccines
By Deena Beasley
Reuters
(Reuters) - Resuming the use of Johnson & Johnson s COVID-19 vaccine in the United States will require clear guidelines for the medical community on how to best treat patients that develop a rare type of blood clot, as well as alerting vaccine recipients to be aware of the telltale symptoms, according to heart doctors and other medical experts.
U.S. health regulators recommended last week that use of the J&J vaccine be paused after six cases of rare brain blood clots, accompanied by low platelet levels, were reported in women following vaccination, out of some 7 million people who have received the shot in the United States. A panel of expert advisors to U.S. health agencies will meet later this week to determine whether the pause should continue, with a decision expected as early as Friday.
Message :
Required fields
April 19 (Reuters) - Resuming the use of Johnson & Johnson s
COVID-19 vaccine in the United States will require clear
guidelines for the medical community on how to best treat
patients that develop a rare type of blood clot, as well as
alerting vaccine recipients to be aware of the telltale
symptoms, according to heart doctors and other medical experts.
U.S. health regulators recommended last week that use of the
J&J vaccine be paused after six cases of rare brain blood clots,
accompanied by low platelet levels, were reported in women
following vaccination, out of some 7 million people who have
Vartan Gregorian Dead At 87
April 19, 2021
Vartan Gregorian, who led the Carnegie Corporation of New York for more than two decades, revitalized The New York Public Library during the 1980s, and served as president of Brown University, died suddenly on April 15 at age 87. He had been hospitalized for testing due to stomach pain, according to the Carnegie Corporation.
“Vartan Gregorian served the Corporation for 24 years as an extraordinary leader and a devoted steward of Andrew Carnegie’s legacy,” Thomas H. Kean, chair of the Carnegie Corporation of New York board of trustees and former governor of New Jersey, said via a statement. “We will remember him most for his immense intellect, his thoughtful generosity, his witty, learned, and sly sense of humor, and his uncanny ability to both inspire and challenge each of us to do our utmost to advance the Corporation’s mission above all else. He was a man of the world who inspired the world.”
Synopsis
U.S. health regulators recommended last week that use of the J&J vaccine be paused after six cases of rare brain blood clots, accompanied by low platelet levels, were reported in women following vaccination, out of some 7 million people who have received the shot in the United States.
Reuters
Johnson & Johnson s coronavirus disease (COVID-19) vaccines
Resuming the use of Johnson & Johnson s COVID-19 vaccine in the United States will require clear guidelines for the medical community on how to best treat patients that develop a rare type of blood clot, as well as alerting vaccine recipients to be aware of the telltale symptoms, according to heart doctors and other medical experts.
Doctors say clot treatment advice key to US resuming J&J COVID vaccines ksl.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksl.com Daily Mail and Mail on Sunday newspapers.